Xeomin units are a standardized measure used by providers to plan a safe, balanced, and effective treatment. These units allow for precise dosing to target specific muscles responsible for dynamic wrinkles, helping to achieve your desired aesthetic outcome.

• Units are individualized: Your provider tailors the dose to your specific needs, muscle strength, and desired look.
• "Per side" matters: Some areas are treated on both sides of the face, so totals may be split.
• Consultation first: Your injector confirms the best plan for symmetry, safety, and natural results.

Common treatment areas (typical ranges may include):

• Eyebrow lift: 2-5 units (per side)
• Forehead lines: 4-16 units
• "11s" frown lines: 10-30 units
• Crow's feet: 8-12 units (per side)
• Nasalis lines: 6-10 units
• Upper lip (lip flip): 4-8 units
• Smile lift: 3-6 units
• Jawline: 10-30 units (per side)

These ranges are educational estimates; the exact number of units required is determined during your personalized consultation with a licensed provider, based on your facial anatomy and desired results.

Xeomin is a wrinkle-reducing cosmetic injectable designed to relax targeted facial muscles, which can help soften the appearance of moderate to severe frown lines, forehead lines, and crow's feet. The treatment works to reduce muscle activity in specific areas, allowing for smoother skin and a more refreshed appearance while preserving natural facial expression. While individual results vary, the effects typically begin within a few days, with optimal results appearing around two weeks, and can last approximately three to four months. Your provider will discuss anticipated outcomes and set expectations during your consultation.

To prepare for your Xeomin treatment, it is generally recommended to avoid alcohol and blood-thinning medications or supplements for 24-48 hours before your appointment, if medically appropriate. Discuss any medications or health concerns with your provider during the consultation. Arrive with a clean face, free of makeup.